NP2GO Review
Best for: Cost-sensitive patients in any of the 39 supported states + DC who want transparent per-dose pricing with the flexibility to choose Pay As You Go or Month-to-Month Membership. Particularly suited for Oklahoma residents who can access the in-person Edmond office + the additional Oklahoma-only services on one platform.
NP2GO (thenp2go.com) is a 7-year-old nurse-practitioner-led hybrid telehealth and physical-clinic operation based in Edmond, Oklahoma (800 W 18th St. Ste. 220, Edmond, OK 73013), founded in 2019 as a woman-owned small business. Virtual weight-loss visits are available in 39 states plus Washington, D.C. (NOT authorized: AL, GA, IN, LA, MO, MS, NC, OH, SC, TN, WI). The platform is multi-product — weight loss (compounded semaglutide + tirzepatide), hormone therapy, peptides, IV hydration, urgent care, aesthetics — but several non-weight-loss services are Oklahoma-only or OKC-Metro-only. NP2GO publishes its complete pricing matrix publicly with explicit per-dose tiers, offering both 'Pay As You Go' (lower per-dose cost, $99 visit fee every 3 months) and 'Month-to-Month Membership' (flat-rate per dose) options. Providers are nurse practitioners affiliated with the Obesity Medicine Association.
High confidence · Last verified 2026-05-15 via manual · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
NP2GO is one of the most affordable GLP-1 options on the market.
Score Breakdown
Drugs Offered
NP2GO prescribes the following GLP-1 medications. Tap a drug to read our clinical guide with FDA label info, dosing schedules, side effects, and trial data.
Pricing
| Dose | Form | Price/mo |
|---|---|---|
| 0.25mg (Pay As You Go) | compounded | $150 |
| 0.50mg (Pay As You Go) | compounded | $175 |
| 1mg (Pay As You Go) | compounded | $235 |
| 1.7mg (Pay As You Go) | compounded | $250 |
| 2.5mg (Pay As You Go) | compounded | $350 |
| 0.25-1mg (Month-to-Month Membership) | compounded | $199 |
| 1.7-2.5mg (Month-to-Month Membership) | compounded | $299 |
| 2.5mg (Pay As You Go) | compounded | $250 |
| 5mg (Pay As You Go) | compounded | $300 |
| 7.5mg (Pay As You Go) | compounded | $375 |
| 10mg (Pay As You Go) | compounded | $475 |
| 12.5mg (Pay As You Go) | compounded | $550 |
| 15mg (Pay As You Go) | compounded | $600 |
| 2.5-7.5mg (Month-to-Month Membership) | compounded | $299 |
| 10-15mg (Month-to-Month Membership) | compounded | $399 |
✓ Pros
- •Fully transparent per-dose pricing matrix published publicly — patient can see cost at every dose tier before committing
- •Dual pricing model (Pay As You Go vs Month-to-Month Membership) lets patients optimize for their consumption pattern — light users save on PAYG, heavy users save on membership
- •Compounded semaglutide entry-level 0.25mg dose at $150/mo (Pay As You Go) is competitive with the lower end of the compounded market ($149-$199/mo)
- •39 states + DC coverage is broad
- •Files prior authorizations on patient's behalf — uncommon for compounded telehealth platforms
- •Nurse-practitioner-led care with Obesity Medicine Association affiliation
- •Hybrid model: in-person Oklahoma City Metro office option for OK residents + virtual nationwide
- •Multi-product platform for OK residents (hormones, IV, urgent care, aesthetics) amortizes the per-visit fee across additional services
- •Established 2019, 40,000+ patients served, 700+ 5-star Google reviews — long-tenure operational track record
- •Visit fee structure (one fee every 3 months for PAYG model) is unusually cost-efficient vs typical $99 monthly visit fees
✗ Cons
- •Tirzepatide high-dose pricing ($475-$600/mo for 10-15mg PAYG) is well above the lowest-cost compounded market floor; Month-to-Month Membership at $399/mo for the same doses is the better choice for high-dose patients
- •Not LegitScript-approved (no badge displayed on public pages) — accreditation transparency gap vs LegitScript-listed competitors
- •Compounding pharmacy partner NOT named publicly (FAQ promises pharmacy disclosure but accordion was not expandable in our test)
- •Service is NOT available in 11 states (AL, GA, IN, LA, MO, MS, NC, OH, SC, TN, WI) — patients in Southeast US and Midwest have limited access
- •Peptide therapy, hormone optimization, and aesthetic services are Oklahoma-only — multi-product positioning is OK-centric rather than nationwide
- •$99 visit fee every 3 months on Pay As You Go is in addition to the per-dose cost — total cost for a 0.25mg PAYG patient is $150/mo + ($99/3 = $33/mo) ≈ $183/mo all-in (still competitive)
- •Marketing claim 'biggest medical weight loss clinic in the United States' on /weight-loss-clinic-of-oklahoma/ page appears overstated — 40K patients served is moderate scale, not market-leading
Ready to start with NP2GO?
Starting at $150/month. See current pricing and start your free consultation.
Sources & methodology
Our NP2GO review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of May 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Alternatives to NP2GO
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Ready to start with NP2GO?
Starting at $150/month. See current pricing and start your free consultation.